Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT04546620 |
| Title | Acalabrutinib in Combination With R-CHOP for Previously Untreated Diffuse Large B-cell Lymphoma (DLBCL) (REMoDL-A) |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | University Hospital Southampton NHS Foundation Trust |
| Indications | |
| Therapies |
Cyclophosphamide + Doxorubicin + Prednisolone + Rituximab + Vincristine Sulfate Acalabrutinib + Cyclophosphamide + Doxorubicin + Prednisolone + Rituximab + Vincristine Sulfate |
| Age Groups: | senior | child | adult |
| Covered Countries |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Colchester General Hospital | Recruiting | Colchester | Essex | United Kingdom | Details | |
| East Kent Hospitals NHS Foundation Trust | Recruiting | Canterbury | Kent | United Kingdom | Details | |
| Nottingham City Hospital | Recruiting | Nottingham | United Kingdom | Details |